Keapstone Therapeutics
Keapstone Therapeutics is a single asset biotech developing drugs that target the Nrf2 signalling pathway (KEAP1 inhibitors) for two devastating conditions – Parkinson’s and Motor Neuron Disease (MND)...
Keapstone Therapeutics's Basic Information
Headquarters
Benin
Website
Founded Year
2017
Headcount
2 - 10
Keapstone Therapeutics's Competitors
Hygieia Biological Laboratories
Woodland, California, United States
Invitrogen
Galapagos
Belgium
BioArra
Eagleville, Pennsylvania, United States
Celecure AS
Tallinn, Estonia
Find Your Next Customer with Better Data
Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.
⭐Top-ranked on G2 Crowd
🛡️GDPR compliant•Cancel anytime
✨Free credits every month!
Frequently Asked Questions Regarding Keapstone Therapeutics
Where is Keapstone Therapeutics's headquarter located?
Keapstone Therapeutics's headquarter are located at Benin.
How many employees does Keapstone Therapeutics have?
Keapstone Therapeutics has 2 - 10 employees.
What is Keapstone Therapeutics's official website?
Keapstone Therapeutics's official website is http://keapstone.com
What does Keapstone Therapeutics do?
Keapstone Therapeutics is a single asset biotech developing drugs that target the Nrf2 signalling pathway (KEAP1 inhibitors) for two devastating conditions – Parkinson’s and Motor Neuron Disease (MND)...
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
